Temperature-sensitive liposome-mediated delivery of thrombolytic agents

References

• Pierce T, Razzuk M, Razzuk L, Hoover S. A comprehensive review of the physiology of hemostasis and antithrombotic agents. BUMC Proc 1999;12:39–49
   Google Scholar
• Patel SC, Mody A. Cerebral hemorrhagic complications of thrombolytic therapy. Prog Cardiovasc Dis 1999;42:217–33
   PubMedGoogle Scholar
• Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991;78:3114–24
   PubMed Web of Science ®Google Scholar
• Eppler S, Senn T, Gilkerson E, Modi NB. Pharmacokinetics and pharmacodynamics of recombinant tissue-type plasminogen activator following intravenous administration in rabbits: A comparison of three dosing regimens. Biopharm Drug Dispos 1998;19:31–8
   PubMed Web of Science ®Google Scholar
• Martins S, Sarmento B, Ferreira DC, Souto EB. Lipid-based colloidal carriers for peptide and protein delivery – Liposomes versus lipid nanoparticles. Int J Nanomedicine 2007;2:595–607
   PubMed Web of Science ®Google Scholar
• Nguyen PD, Orear EA, Johnson AE, Patterson E, Whitsett TL, Bhakta R. Accelerated thrombolysis and reperfusion in a canine model of myocardial-infarction by liposomal encapsulation of streptokinase. Circ Res 1990;66:875–8
   PubMed Web of Science ®Google Scholar
• Tiukinhoy-Laing SD, Huang SL, Klegerman M, Holland CK, McPherson DD. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. Thromb Res 2007;119:777–84
   PubMed Web of Science ®Google Scholar
• Vanderschueren S, Barrios L, Kerdsinchai P, Vandenheuvel P, Hermans L, Vrolix M, et al. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. Circulation 1995;92:2044–9
   PubMedGoogle Scholar
• Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky RL, Sardar P, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: A meta-analysis. JAMA 2014;311:2414–21
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: An updated systematic review and meta-analysis. Lancet 2012;379:2364–72
   PubMed Web of Science ®Google Scholar
• Cohen A. Pharmacokinetics of the recombinant thrombolytic agents – What is the clinical significance of their different pharmacokinetic parameters? Biodrugs 1999;11:115–23
   PubMed Web of Science ®Google Scholar
• Modi NB, Eppler S, Breed J, Cannon CP, Braunwald E, Love TW. Pharmacokinetics of a slower clearing tissue plasminogen activator variant, TNK-tPA, in patients with acute myocardial infarction. Thromb Haemostasis 1998;79:134–9
   PubMed Web of Science ®Google Scholar
• Elbayoumi TA, Torchilin VP. Liposomes for targeted delivery of antithrombotic drugs. Expert Opin Drug Deliv 2008;5:1185–98
   PubMed Web of Science ®Google Scholar
• Zhang X, Luckham PF, Hughes AD, Thom S, Xu XY. Development of lysolipid-based thermosensitive liposomes for delivery of high molecular weight proteins. Int J Pharmaceutics 2011;421:291–2
   PubMedGoogle Scholar
• Laing ST, Moody MR, Kim H, Smulevitz B, Huang SL, Holland CK, et al. Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model. Thromb Res 2012;130:629–35
   PubMed Web of Science ®Google Scholar
• Tiukinhoy-Laing SD, Buchanan K, Parikh D, Huang SL, MacDonald RC, McPherson DD, et al. Fibrin targeting of tissue plasminogen activator-loaded echogenic liposomes. J Drug Target 2007;15:109–14
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Targeting of drugs and drug carriers within the cardiovascular system. Adv Drug Deliv Rev 1995;17:75–101
   Web of Science ®Google Scholar
• Heeremans JLM, Prevost R, Bekkers MEA, Los P, Emeis JJ, Kluft C, et al. Thrombolytic treatment with tissue-type plasminogen-activator (t-PA)-containing liposomes in rabbits – A comparison with free t-PA. Thromb Haemostasis 1995;73:488–94
   PubMed Web of Science ®Google Scholar
• May JP, Li SD. Hyperthermia-induced drug targeting. Expert Opin Drug Deliv 2013;10:511–27
   PubMed Web of Science ®Google Scholar
• Lindner LH, Eichhorn ME, Eibl H, Teichert N, Schmitt-Sody M, Issels RD, et al. Novel temperature-sensitive liposomes with prolonged circulation time. Clin Cancer Res 2004;10:2168–78
   PubMed Web of Science ®Google Scholar
• Lindner LH, Hossann M, Vogeser M, Teichert N, Wachholz K, Eibl H, et al. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: Active ingredient and mediator of drug release. J Control Release 2008;125:112–20
   PubMed Web of Science ®Google Scholar
• Needham D, Dewhirst MW. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliv Rev 2001;53:285–305
   PubMed Web of Science ®Google Scholar
• Li L, ten Hagen TLM, Schipper D, Wijnberg TM, van Rhoon GC, Eggermont AMM, et al. Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia. J Control Release. 2010;143:274–9
   PubMed Web of Science ®Google Scholar
• Lijnen HR, Vanhoef B, Decock F, Okada K, Ueshima S, Matsuo O, et al. On the mechanism of fibrin-specific plasminogen activation by staphlokinase. J Biol Chem 1991;266:11826–32
   PubMed Web of Science ®Google Scholar
• Alexandrov AV. Current and future recanalization strategies for acute ischemic stroke. J Intern Med 2010;267:209–19
   PubMed Web of Science ®Google Scholar
• Yeo LLL, Sharma VK. The quest for arterial recanalization in acute ischemic stroke – The past, present and the future. J Clin Med Res 2013;5:251–265
   PubMedGoogle Scholar
• Tapson VF. Thrombolytic therapy for acute pulmonary embolism. Semin Thromb Hemost 2013;39:7
   Google Scholar
• Block HS, Biller J. Commonly asked questions: Thrombolytic therapy in the management of acute stroke. Expert Rev Neurother 2013;13:157–65
   PubMed Web of Science ®Google Scholar
• Stefanadis C, Diamantopoulos L, Vlachopoulos C, Tsiamis E, Dernellis J, Toutouzas K, et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo – A new method of detection by application of a special thermography catheter. Circulation 1999;99:1965–71
   PubMed Web of Science ®Google Scholar
• Toutouzas K, Synetos A, Stefanadi E, Vaina S, Markou V, Vavuranakis M, et al. Correlation between morphologic characteristics and local temperature differences in culprit lesions of patients with symptomatic coronary artery disease. J Am Coll Cardiol 2007;49:2264–71
   PubMedGoogle Scholar
• Armstrong JK, Wenby RB, Meiselman HJ, Fisher TC. The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. Biophys J 2004;87:4259–70
   PubMed Web of Science ®Google Scholar
• Scherphof G, Roerdink F, Waite M, Parks J. Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. Biochim Biophys Acta 1978;542:296–307
   PubMed Web of Science ®Google Scholar
• Shabbits JA, Chiu GNC, Mayer LD. Development of an in vitro drug release assay that accurately predicts in vivo drug retention for liposome-based delivery systems. J Control Release 2002;84:161–70
   PubMed Web of Science ®Google Scholar
• Hossann M, Syunyaeva Z, Schmidt R, Zengerle A, Eibl H, Issels RD, et al. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes. J Control Release 2012;162:400–6
   PubMed Web of Science ®Google Scholar
• Shaw GJ, Meunier JM, Huang SL, Lindsell CJ, McPherson DD, Holland CK. Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes. Thromb Res 2009;124:306–10
   PubMed Web of Science ®Google Scholar
• Vanderschueren S, Dens J, Kerdsinchai P, Desmet W, Vrolix M, DeMan F, et al. Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarction. Am Heart J 1997;134:213–19
   PubMedGoogle Scholar
• Mandi N, Soorapaneni S, Rewanwar S, Kotwal P, Prasad B, Mandal G, et al. High yielding recombinant staphylokinase in bacterial expression system-cloning, expression, purification and activity studies. Protein Expr Purif 2009;64:69–75
   PubMed Web of Science ®Google Scholar
• Prasad B, Salunkhe SS, Padmanabhan S. Novel self-cleavage activity of staphylokinase fusion proteins: An interesting finding and its possible applications. Protein Expression Purification 2010;69:191–7
   PubMedGoogle Scholar
• Kumar S, Maheshwari N, Sahni G, inventors. Mutants of streptokinase and their covalently modified forms. US Patent 20100034804 A1, 2010
   Google Scholar
• Collen D, Bernaerts R, Declerck P, DeCock F, Demarsin E, Jenne S, et al. Recombinant staphylokinase variants with altered immunoreactivity. 1. Construction and characterization. Circulation 1996;94:197–206
   PubMed Web of Science ®Google Scholar
• Collen D, Moreau H, Stockx L, Vanderschueren S. Recombinant staphylokinase variants with altered immunoreactivity. 1. Thrombolytic properties and antibody induction. Circulation 1996;94:207–16
   PubMed Web of Science ®Google Scholar
• Collen D, DeCock F, Demarsin E, Jenne S, Lasters I, Laroche Y, et al. Recombinant staphylokinase variants with altered immunoreactivity. 3. Species variability of antibody binding patterns. Circulation 1997;95:455–62
   PubMedGoogle Scholar
• Liu J, Wang Z, He J, Wang G, Zhang R, Zhao B. Effect of site-specific PEGylation on the fibrinolytic activity, immunogenicity, and pharmacokinetics of staphylokinase. Acta Biochim Biophys Sin 2014;46:782–91
   Google Scholar
• Edgell T, McEvoy F, Webbon P, Gaffney PJ. Monoclonal antibodies to human fibrin: Interaction with other animal fibrins. Thromb Haemostasis 1996;75:595–9
   PubMedGoogle Scholar
• Klegerman ME, Zou Y, McPherson DD. Fibrin targeting of echogenic liposomes with inactivated tissue plasminogen activator. J Liposome Res 2008;18:95–112
   PubMed Web of Science ®Google Scholar
• Sen Gupta A, Huang G, Lestini BJ, Sagnella S, Kottke-Marchant K, Marchant RE. RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system. Thromb Haemostasis 2005;93:106–14
   PubMed Web of Science ®Google Scholar
• Peters D, Kastantin M, Kotamraju VR, Karmali PP, Gujraty K, Tirrell M, et al. Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci USA 2009;106:9815–19
   PubMed Web of Science ®Google Scholar
• Frenkel V, Kimmel E, Iger Y. Ultrasound-induced cavitation damage to external epithelia of fish skin. Ultrasound Med Biol 1999;25:1295–303
   PubMedGoogle Scholar
• Nightingale K, Soo MS, Nightingale R, Trahey G. Acoustic radiation force impulse imaging: In vivo demonstration of clinical feasibility. Ultrasound Med Biol 2002;28:227–35
   PubMed Web of Science ®Google Scholar
• Stone MJ, Frenkel V, Dromi S, Thomas P, Lewis RP, Li KC, et al. Pulsed high intensity focused ultrasound enhanced tPA mediated thrombolysis in a novel in vivo clot model: A pilot study. Thromb Res 2007;121:193–202
   PubMed Web of Science ®Google Scholar
• Frenkel V, Oberoi J, Stone MJ, Park M, Deng C, Wood BJ, et al. Pulsed high-intensity focused ultrasound enhances thrombolysis in an in vitro model. Radiology 2006;239:86–93
   PubMed Web of Science ®Google Scholar
• Lin PH, Annambhotla S, Bechara CF, Athamneh H, Weakley SM, Kobayashi K, et al. Comparison of percutaneous ultrasound-accelerated thrombolysis versus catheter-directed thrombolysis in patients with acute massive pulmonary embolism. Vascular 2009;17:S137–47
   PubMed Web of Science ®Google Scholar